Sample Size Determination for Three-Level Randomized Clinical Trials with Randomization at the First or Second Level

Author：

ISSN： 1054-3406

Source： Journal of Biopharmaceutical Statistics, Vol.24, Iss.3, 2014-05, pp. : 579-599

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Calculation of Tolerance Limits and Sample Size Determination for Clinical Trials with Dichotomous Outcomes

By Zaslavsky Boris G.

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 3, 2007-05 ,pp. : 481-491

Taylor & Francis Ltd

Access to resources Recommend Favorite

Sample Size Determination for Clinical Trials in Patients with Nonlinear Disease Progression

By Yan Xin

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 1, 2006-01 ,pp. : 91-105

Taylor & Francis Ltd

Access to resources Recommend Favorite

Impact of Subject Attrition on Sample Size Determinations for Longitudinal Cluster Randomized Clinical Trials

Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 3, 2014-05 ,pp. : 507-522

Taylor & Francis Ltd

Access to resources Recommend Favorite

Sample Size Determination for Cost-Effectiveness Trials

By Willan Andrew R.

PharmacoEconomics, Vol. 29, Iss. 11, 2011-11 ,pp. : 933-949

Adis International

Access to resources Recommend Favorite

Sample Size Determination in Superiority Clinical Trials with Multiple Co-Primary Correlated Endpoints

By Sozu Takashi

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 4, 2011-07 ,pp. : 650-668

Taylor & Francis Ltd

Access to resources Recommend Favorite